Quick Takeaways
- ACORN BIOVENTURES, L.P. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $9,098,765.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of ACORN BIOVENTURES, L.P.
- Location
- New York, NY
- Summary
- The estimated net worth of ACORN BIOVENTURES, L.P. is at least $9,098,765 dollars as of 19 May 2025. ACORN BIOVENTURES, L.P. is the 10%+ Owner of OnKure Therapeutics, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $9.1M.
- Signature
- ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow ACORN BIOVENTURES, L.P. and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: OnKure Therapeutics, Inc. ($9,098,765).
- Past-year value change for that position: +$2,590,000.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of ACORN BIOVENTURES, L.P.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | 10%+ Owner | $9,098,765 | +$2,590,000 | +40% | 15 May 2025 |
Insider Transactions Reported by ACORN BIOVENTURES, L.P.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.